Predict the future by creating it

Pro-Position.AI for HealthTech

Hero

Eyebrow: BUILT FOR HEALTHTECH PRODUCT & GTM TEAMS Headline: Clinical credibility and compliance decide HealthTech deals. Track both. Subhead: HealthTech buyers screen for HIPAA compliance, clinical validation, and EHR/EMR integration depth before functionality ever enters the conversation. Pro-Position.AI tracks the signals that actually move HealthTech competitive position — certifications, clinical partnerships, interoperability standards, and the regulatory announcements your buyers are watching too. CTA primary: See HealthTech battlecards → CTA secondary: Book a 20-min demo

Why generic CI tools miss HealthTech

A feature comparison means little to a healthcare buyer if a competitor doesn't have HIPAA compliance, HL7/FHIR interoperability, or a relevant clinical validation study. Generic CI platforms don't track FDA clearance status, EHR integration partnerships, or clinical evidence publication — all of which can change a competitor's standing in a deal far more than a new feature release.

Core benefits

Compliance and certification tracking as standard HIPAA compliance status, FDA clearance updates, and security certifications are tracked alongside product and pricing intelligence — first-tier data, not an afterthought.

EHR/EMR and interoperability partnership signal Track which competitors are landing new Epic, Cerner, or other EHR integrations — often the deciding factor in enterprise health system deals.

Battlecards built for clinical and compliance scrutiny Fast Facts lead with certification and integration status, with counterpoints prepared for the objections health system buyers actually raise.

Roadmap evidence from clinical and provider feedback CAB transcription and keyword extraction are built to handle clinician interviews and provider advisory sessions, surfacing language your roadmap can act on without a manual review pass.

What gets monitored

HIPAA / compliance certification status · FDA clearance and regulatory filings · EHR/EMR integration and interoperability partnerships · clinical validation studies and publications · funding and M&A activity · job postings signalling clinical or regulatory hiring

FAQ

"Our buyers are hospital systems with multi-year evaluation cycles — does real-time intelligence even matter here?" Yes — long cycles mean more time for the competitive landscape to shift mid-evaluation. Knowing a competitor gained an Epic integration or lost FDA clearance six months into a 14-month sales cycle is exactly when it matters most.

"Can the platform distinguish between point solutions and full clinical platforms as competitors?" Competitor profiles are fully custom — track a narrow point-solution competitor with the same depth as a full platform player, without forcing an apples-to-oranges comparison.

Closing CTA: "Walk into the next health system RFP already knowing where you stand." → Book a Demo